A. Bjartell

发表

Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database

Catherine Han Lin, D. Nieboer, E. Steyerberg, 2022, The Prostate.

Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer

A. Bjartell, R. Massoumi, K. Ahlqvist, 2013, Oncogene.

Artificial intelligence for detection of prostate cancer in biopsies during active surveillance.

A. Krzyzanowska, F. Marginean, A. Simoulis, 2024, BJU international.

Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.

Joeran S. Bosma, N. Obuchowski, Derya Yakar, 2024, The Lancet. Oncology.

Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy.

S. McCarthy, S. Mundle, A. Bhaumik, 2024, BJU international.

Platinum Priority – Collaborative Review – Prostate Cancer MicroRNA in Prostate , Bladder , and Kidney Cancer : A Systematic Review

F. Hamdy, T. Visakorpi, O. Kallioniemi, 2011 .

Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.

R. V. D. van den Bergh, A. Briganti, S. Rasul, 2023, European urology oncology.

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).

H. Beltran, M. Matikainen, N. Fossati, 2024, European urology.

Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI’s “big data for better outcomes” program

M. Roobol, J. Gómez Rivas, T. Murtola, 2023, International journal of surgery protocols.